Warren Buffett’s Firm Invests Millions in Fintech (The Wall Street Journal) Warren Buffett’s Berkshire Hathaway Inc. is hopping on the fintech bandwagon...
Keep Reading →
October 29 - Hedge Funds, Insider Trading - Comments
Ken Griffin Hires Two Moore Capital Veterans for Macro Expansion (Bloomberg) Billionaire Ken Griffin hired two veteran money managers from Louis Bacon...
Keep Reading →
October 2 - Hedge Funds, Insider Trading - Comments
Famed Value Investor Bill Miller Says Facebook Stock has Gotten Too Cheap: ‘This Too will Pass’ (CNBC) Famed investor Bill Miller is still...
Keep Reading →
March 21 - Hedge Funds, Insider Trading - Comments
President Donald Trump in his inaugural speech to a joint session of Congress characterized the approval process of drugs at the U.S. Food and Drug Administration...
Keep Reading →
March 2 - News, Stock Analysis - Comments
Amicus Therapeutics, Inc. (NASDAQ:FOLD) says that it will be closing its previously announced private offering of $250 million aggregate principal amount...
Keep Reading →
December 22 - News, Stock Analysis - Comments
Amicus Therapeutics, Inc. (NASDAQ:FOLD) just announced a convertible senior notes offering, and the company is trending down on he back of the news. Here...
Keep Reading →
December 15 - News, Stock Analysis - Comments
It’s time to take a look at those stocks that really moved over the last twenty-four hours or so in biotech, and there are plenty to go at. It’s been...
Keep Reading →
November 29 - Market Movers, News, Stock Analysis - Comments
While wider markets turn there focus to the US elections, the biotech space is alive and well, and after a tough end to last week, a number of companies...
Keep Reading →
November 8 - Market Movers, News - Comments
The healthcare sector has witnessed a significant correction in the last 15 months, with many prominent names in the industry losing a noteworthy chunk...
Keep Reading →
October 8 - Hedge Funds, News - Comments
Redmile Group is a San Francisco-based, healthcare-focused hedge fund founded and managed by Jeremy Green, an Oxford alum with more than 20 years of experience...
Keep Reading →
June 3 - Hedge Fund Analysis, Hedge Funds, News - Comments
Amicus Therapeutics, Inc. (NASDAQ:FOLD)’s lead drug candidate is migalastat, which targets Fabry disease. An estimated 1 in 40,000 to 60,000 males...
Keep Reading →
May 21 - News - Comments
The markets are going nowhere today, after the IMF cut its global growth forecast for the fourth time over the past twelve months, due to China’...
Keep Reading →
April 12 - Market Movers, News - Comments
Oil went back to tumbling on Friday, with crude oil losing more than 3.5%. On the other hand, markets returned to positive territory, with major U.S....
Keep Reading →
April 1 - Market Movers, News - Comments
Bloomberg recently came out with its list of best performing hedge funds of 2015 and the fund that managed to beat all its rivals and emerge at the top...
Keep Reading →
February 27 - Hedge Funds, News - Comments
Redmile Group is a San Francisco-based investment firm managed by Jeremy Green, which primarily focuses on the healthcare sector. Redmile has an equity...
Keep Reading →
February 26 - Hedge Funds, News - Comments
Over the past few months the healthcare sector has undergone a roller coaster of a ride, especially in August and September when many investors got wary...
Keep Reading →
December 20 - Hedge Funds, News - Comments
Given elite hedge funds have filed their latest 13F’s, we have an opportunity to analyze what hedge funds like and what they don’t like. Since...
Keep Reading →
December 11 - Hedge Funds, News - Comments
Shareholders of Amicus Therapeutics, Inc. (NASDAQ:FOLD), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Novavax, Inc. (NASDAQ:NVAX), and Diamond Offshore...
Keep Reading →
November 2 - Market Movers, News - Comments
It’s a good Monday for investors of ContraVir Pharmaceuticals Inc (NASDAQ:CTRV), Amicus Therapeutics, Inc. (NASDAQ:FOLD), and Oasis Petroleum Inc. (...
Keep Reading →
October 5 - Market Movers, News - Comments
Three stocks trending significantly low today before afternoon were Amicus Therapeutics, Inc. (NASDAQ:FOLD), which cratered by more than 40%, Teladoc...
Keep Reading →
October 2 - Market Movers, News - Comments
Biotech Guru Joseph Edelman‘s Perceptive Advisors is known for its long-short investment approach that focuses on biotech stocks. Edelman founded...
Keep Reading →
June 25 - Hedge Funds, News - Comments
Ken Griffin‘s Citadel Investment Group has increased its stakes in Tuesday Morning Corporation (NASDAQ:TUES), Swift Transportation Co (NYSE:SWFT...
Keep Reading →
April 28 - Hedge Funds, News - Comments
Jeremy Green‘s Redmile Group has also reduced its stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD), after yesterday, William Leland Edwards’...
Keep Reading →
October 9 - Hedge Funds, News - Comments
William Leland Edwards’ Palo Alto Investors disclosed today a 50% decrease in its exposure to Amicus Therapeutics, Inc. (NASDAQ:FOLD). According to...
Keep Reading →
October 8 - Hedge Funds, News - Comments
Perceptive Advisors, managed by Joseph Edelman, is bullish on Amicus Therapeutics Inc. (NASDAQ:FOLD). In a new filing with the U.S. Securities and Exchange...
Keep Reading →
July 2 - Hedge Funds, News - Comments
Jeremy Green‘s Redmile Group has significantly surged its position in Amicus Therapeutics, Inc. (NASDAQ:FOLD), a new filing with the SEC revealed...
Keep Reading →
November 29 - Hedge Funds, News - Comments
Is BioDelivery Sciences International, Inc. (NASDAQ:BDSI) a good investment? At the moment, there are many indicators market participants can use to...
Keep Reading →
September 17 - News - Comments
Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) a good investment? Now, according to many investors, hedge funds are assumed to be overrated, outdated investment...
Keep Reading →
September 17 - News - Comments
Should Pain Therapeutics, Inc. (NASDAQ:PTIE) investors track the following data? In the eyes of many investors, hedge funds are viewed as overrated,...
Keep Reading →
September 6 - News - Comments
Is ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) a buy, sell, or hold? The best stock pickers are taking a bullish view. The number of bullish hedge fund bets...
Keep Reading →
June 26 - News - Comments
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) shareholders have witnessed a decrease in hedge fund sentiment of late; stagnant interest is a...
Keep Reading →
June 13 - News - Comments
Is Pain Therapeutics, Inc. (NASDAQ:PTIE) a buy, sell, or hold? The smart money is in a bearish mood. The number of long hedge fund positions were trimmed...
Keep Reading →
June 10 - News - Comments
Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) a marvelous investment today? Money managers are becoming less confident. The number of bullish hedge fund...
Keep Reading →
April 13 - News - Comments
Horse meat and Wal-Mart Stores, Inc. (NYSE:WMT) jockeyed for position in sending the Dow Jones Industrial Average lower on Friday, but the index fought...
Keep Reading →
February 20 - News - Comments
With the SPDR S&P Biotech Index up 20% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the...
Keep Reading →
February 18 - News - Comments
The Ides of March meant bad news for Julius Caesar. Similarly, the week surrounding the Ides of February haven’t turned out so well for several...
Keep Reading →
February 16 - News - Comments
Buckeye Partners, L.P. (NYSE:BPL) recently announced plans to issue additional limited partnership units. Citigroup Inc. (NYSE:C) issued preferred shares...
Keep Reading →
February 5 - News - Comments
If you believe in the wisdom of analysts, you probably find stocks that have discrepancies between current price and target price attractive investments...
Keep Reading →
December 20 - Stock Analysis - Comments
